| Related party revenue | |
| Technology and license revenue | 0 |
| Grant revenue | |
| Total revenues | |
| Research and development | 2K |
| General and administrative | 2.99M |
| Restructuring charge | |
| Total operating expenses | 2.99M |
| Loss from operations | -2.99M |
| Interest income and other income, net | -243K |
| Loss from continuing operations before income taxes | -3.2M |
| Income tax benefit for continuing operations | 0 |
| Loss from continuing operations | |
| Income (loss) from discontinued operations | |
| Gain on sale of discontinued operations | |
| Income tax expense for discontinued operations | |
| Income from discontinued operations | |
| Net income (loss) | -3.2M |
| Net income (loss) attributable to non-controlling interests | 0 |
| Net income (loss) attributable to Maxygen, Inc. | -3.2M |
| Continuing operations | |
| Discontinued operations | |
| Attributable to Maxygen, Inc. | |
| Shares used in basic and diluted net income (loss) per share calculations | |